# RESEARCH ON FACTORS OF RESISTANCE TO CHEMOTHERAPY AND INNOVATIVE THERAPIES IN MATURE B-CELL LYMPHOIDS

> **NCT07385612** · — · NOT_YET_RECRUITING · sponsor: **Nantes University Hospital** · enrollment: 80 (estimated)

## Conditions studied

- MATURE B-CELL LYMPHOIDS

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07385612
- **Lead sponsor:** Nantes University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-03-01
- **Primary completion:** 2026-03-01
- **Final completion:** 2026-03-01
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2026-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07385612

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07385612, "RESEARCH ON FACTORS OF RESISTANCE TO CHEMOTHERAPY AND INNOVATIVE THERAPIES IN MATURE B-CELL LYMPHOIDS". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT07385612. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*